Hey, Novartis. GTO Could Use $600 Million, Too

Dec 03, 2007

This piece gets in on big-money merit. Check out the Wall Street Journal for a quick story about Novartis and MorphoSys, a German biotech, expanding their collaboration -- to the tune of a 10-year, $600 million partnership. The alliance is geared toward "the discovery and development of antibody-based biological drugs," according to the article.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

To Keep Up

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

On the Rise in the City

The New York Times reports that a new viral variant of concern has been identified in New York City.

Nature Studies Present Single-Cell Map of Cell Cycle, Approach Identifies Cancer Treatment Resistance Pathways, More

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Menu